Venous thromboembolism and risk of idiopathic interstitial pneumonia: A nationwide study

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 10, 2010, Pages 1085-1092

  Sode, Birgitte F ^a   Dahl, Morten ^a   Nielsen, Sune F ^a   Nordestgaard, Børge G ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Anticoagulants; Blood coagulation factors; Embolism; Lung diseases, interstitial; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CHILD; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; VENOUS THROMBOEMBOLISM; CASE CONTROL STUDY; DENMARK; HEALTH SURVEY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER;

ADULT; AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; REGISTRIES; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77953241528     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200912-1951OC     Document Type: Article

References (25)

1. Gudmundsson G, Hunninghake G. Interstitial and restrictive pulmonary disorders. In: Rimoin D, Connor JM, Pyeritz RE, Korf BR, eds. Principles and practice of medical genetics, 5th ed. Philadelphia, PA: Churcilll Livingstone Elsevier; 2007. pp. 1431-1444.
2. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG, Factor V. Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004;140:330-337.
3. Juul K, Tybjaerg-Hansen A, Mortensen J, Lange P, Vestbo J, Nordestgaard BG, Factor V. Leiden homozygosity, dyspnea, and reduced pulmonary function. Arch Intern Med 2005;165:2032-2036. (Pubitemid 41362628)
4. Sode BF, Dahl M, Nielsen SF, Nordestgaard BG. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study [abstract, no. A1109]. American Thoracic Society Meeting, May 14-19, 2010.
5. Pedersen CB, Gøtzsche H, Møller J∅, Mortensen PB. The Danish civil registration system. Dan Med Bull 2006;53:441-449.
6. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva, Switzerland: World Health Organization; 2001.
7. Hubbard RB, Smith C, Le JI, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008;178:1257-1261.
8. Chambers RC, Laurent GJ. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 2002;30:194-200.
9. Chambers RC. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol 2008;153:S367-S378.
10. Dabbagh K, Chambers RC, Laurent GJ. From clot to collagen: coagulation peptides in interstitial lung disease. Eur Respir J 1998;11:1002-1005. (Pubitemid 28281013)
11. Wygrecka M, Jablonska E, Guenther A, Preissner KT, Markart P. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008;99:494-501. (Pubitemid 351549285)
12. Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ, Chambers RC. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 2001;159:1383-1395. (Pubitemid 32947968)
13. Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001;163:1660-1668. (Pubitemid 32578773)
14. Gunther A, Lubke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, Ruppert C, Quanz K, Ermert L, et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 2003;168:1358-1365. (Pubitemid 37487332)
15. Kijiyama N, Ueno H, Sugimoto I, Sasaguri Y, Yatera K, Kido M, Gabazza EC, Suzuki K, Hashimoto E, Takeya H. Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis. Biochem Biophys Res Commun 2006;339:1113-1119. (Pubitemid 41790579)
16. Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005;128:1475-1482. (Pubitemid 41324435)
17. Howell DCJ, Goldsack NR, Marshall RP, Gray AJ, McAnulty RJ, Laurent GJ, Chambers RC. Direct thrombin inhibition attenuates bleomycin-induced pulmonary fibrosis. Thorax 1999;54:A16.
18. Kobayashi H, Gabazza EC, Taguchi O, Wada H, Takeya H, Nishioka J, Yasui H, Kobayashi T, Hataji O, Suzuki K, et al. Protein C anticoagulant system in patients with interstitial lung disease. Am J Respir Crit Care Med 1998;157:1850-1854.
19. Shimizu S, Gabazza EC, Taguchi O, Yasui H, Taguchi Y, Hayashi T, Ido M, Shimizu T, Nakagaki T, Kobayashi H, et al. Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med 2003;167:1416-1426. (Pubitemid 36609728)
20. Yasui H, Gabazza EC, Taguchi O, Risteli J, Risteli L, Wada H, Yuda H, Kobayashi T, Kobayashi H, Suzuki K, et al. Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease. Clin Appl Thromb Hemost 2000;6:202-205. (Pubitemid 33143850)
21. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-1272.
22. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-2339.
23. Thanassoulis G, O'Donnell CJ. Mendelian randomization: nature's randomized trial in the post-genome era. JAMA 2009;301:2386-2388.
24. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-1908.
25. Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc 2007;82:976-986.